Dubai, United Arab Emirates-Monday 10 January 2022 [ AETOS Wire ]
Arzan Wealth (DIFC) Limited (‘Arzan Wealth’), a Dubai-based advisory firm regulated by the Dubai Financial Services Authority, is pleased to announce that it has advised its client on the sale of the Medical Technology Campus of Glaukos Corporation(“The Property”) located in a highly desirable part of Orange County, California, USA, achieving strong returns for investors.
The sold property houses the headquarters offices of Glaukos as well as their primary R&D facilities. The campus consists of three newly refurbished buildings comprising 159,746sft and fully let to Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. Glaukos was the first company to introduce Micro-Invasive Glaucoma Surgery (MIGS), the micro-invasive procedure which revolutionized the treatment and management of glaucoma.
The Property was acquired in June-2020 as part of Arzan Wealth's yielding asset platform with an objective of producing an average annual yield of 9.15% to investors, and an IRR of around 10.7% over a five-year holding period. Arzan Wealth advised on the exit of this investment at a price that far exceeded initial expectations, and which reflected the success of Arzan Wealth in acquiring the asset at a good price in the midst of the coronavirus pandemic, and the ensuing stabilization of capital markets during 2021.
Muhannad Abulhasan, CEO of Arzan Wealth said:
“The Glaukos new HQ campus is a unique opportunity and high-quality asset offering strong cash flows and solid rental growth, making it an attractive long-term asset for the new buyer. We are delighted to have been able to significantly exceed our investors’ expectations in a short holding period, and deliver very strong returns to our loyal investors. This exit, which is one of several profitable divestments Arzan Wealth has achieved during 2021, ensures our commitment to our investors and our dedication to always working hard on their behalf, to maximize returns and to minimize risks. As always, our primary objective at Arzan Wealth continues to be the protection of our clients’ wealth and legacies, by reducing risks and diversifying income sources for them and their future generations”.
Notes to Editors
About Arzan Wealth (DIFC) Limited
Arzan Wealth is an investment advisory firm registered at the Dubai International Financial Centre (DIFC), and is regulated by the Dubai Financial Services Authority (DFSA). Arzan Wealth currently advises various professional clients on real estate, private equity and other investments with a total value of assets advised around US$ 2.37 Billion. Arzan Wealth focuses on arranging yielding investments in major global markets, as well as bespoke investments that meet the requirements of specific clients. Past or projected performance is not necessarily a reliable indicator of future results. Arzan Wealth (DIFC) Limited accepts no liability for any loss arising from the use of this document or its contents or otherwise arising in connection therewith.
Contacts
Ahmad AlSabbrei
Head of Investment Operations
a.alsabbrei@arzanwealth.com
+965 9988 8624
Permalink : https://www.aetoswire.com/news/arzan-wealth-achieves-successful-exit-of-a-medical-technology-campus-in-usa/en
|